Charles Schwab’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-9,177
| Closed | -$731K | – | 3569 |
|
|
2021
Q2 | $731K | Buy |
9,177
+5,107
| +125% | +$407K | ﹤0.01% | 3040 |
|
|
2021
Q1 | $541K | Hold |
4,070
| – | – | ﹤0.01% | 3051 |
|
|
2020
Q4 | $648K | Buy |
4,070
+167
| +4% | +$26.6K | ﹤0.01% | 2903 |
|
|
2020
Q3 | $411K | Sell |
3,903
-4
| -0.1% | -$421 | ﹤0.01% | 2933 |
|
|
2020
Q2 | $474K | Buy |
3,907
+110
| +3% | +$13.3K | ﹤0.01% | 2851 |
|
|
2020
Q1 | $298K | Sell |
3,797
-26
| -0.7% | -$2.04K | ﹤0.01% | 2893 |
|
|
2019
Q4 | $1.13M | Buy |
3,823
+45
| +1% | +$13.3K | ﹤0.01% | 2557 |
|
|
2019
Q3 | $684K | Buy |
3,778
+549
| +17% | +$99.4K | ﹤0.01% | 2681 |
|
|
2019
Q2 | $1.29M | Buy |
3,229
+353
| +12% | +$141K | ﹤0.01% | 2495 |
|
|
2019
Q1 | $1.34M | Sell |
2,876
-75
| -3% | -$35K | ﹤0.01% | 2466 |
|
|
2018
Q4 | $1.42M | Buy |
2,951
+183
| +7% | +$87.9K | ﹤0.01% | 2431 |
|
|
2018
Q3 | $1.89M | Buy |
2,768
+24
| +0.9% | +$16.4K | ﹤0.01% | 2440 |
|
|
2018
Q2 | $1.87M | Buy |
+2,744
| New | +$1.87M | ﹤0.01% | 2399 |
|